Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      December 2024

      home / publications / oncology-nurse / december-2024

      disparities in cancer care

      Cancer Medication Adherence in the Latinx/Hispanic Community

      Sara Grisales Jaramillo, MSW, LMSW
      December 19th 2024
      ArticlePartner Perspectives

      Understanding psychosocial implications, barriers, risks, and impacts.


      blood cancer

      APP Addresses Management of Abnormal Uterine Bleeding in Stem Cell Transplant

      Amanda Brink, DNP, APRN, FNP-BC, AOCNP
      December 18th 2024
      ArticleAPP Page

      Pharmacologic strategies may be able to prevent abnormal uterine bleeding in patients undergoing stem cell transplant.


      DNA

      How ctDNA Testing Is Being Used To Diagnose And Monitor Cancer

      Linda Childers
      December 18th 2024
      ArticleFeature Story

      The role of circulating tumor DNA is growing: From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.


      biosimilar

      What’s the Difference: Biologics vs Biosimilars in Cancer Care

      Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN
      December 17th 2024
      ArticleNurse's Notes

      Nurses play an important role in the administration of biosimilars and the education of patients receiving them.


      cancer research

      Cancer Care Advancements in 2024 and Beyond

      Mike Hennessy Jr
      December 17th 2024
      ArticleFrom the Chairman

      This past year, the role of ctDNA testing has expanded to guide treatment decisions for providers and patients with cancer.

      Latest Conference Coverage

      Relacorilant Combo Boosts PFS in Resistant Ovarian Cancer

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations

      AI Tool May Predict Response, Resistance in Advanced RCC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.